Aberrant gene expression prediction across human tissues.
Nat. Commun. 16:3061 (2025)
Despite the frequent implication of aberrant gene expression in diseases, algorithms predicting aberrantly expressed genes of an individual are lacking. To address this need, we compile an aberrant expression prediction benchmark covering 8.2 million rare variants from 633 individuals across 49 tissues. While not geared toward aberrant expression, the deleteriousness score CADD and the loss-of-function predictor LOFTEE show mild predictive ability (1-1.6% average precision). Leveraging these and further variant annotations, we next train AbExp, a model that yields 12% average precision by combining in a tissue-specific fashion expression variability with variant effects on isoforms and on aberrant splicing. Integrating expression measurements from clinically accessible tissues leads to another two-fold improvement. Furthermore, we show on UK Biobank blood traits that performing rare variant association testing using the continuous and tissue-specific AbExp variant scores instead of LOFTEE variant burden increases gene discovery sensitivity and enables improved phenotype predictions.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Association
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2025
Prepublished im Jahr
0
HGF-Berichtsjahr
2025
ISSN (print) / ISBN
2041-1723
e-ISSN
2041-1723
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 16,
Heft: 1,
Seiten: ,
Artikelnummer: 3061
Supplement: ,
Reihe
Verlag
Nature Publishing Group
Verlagsort
London
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30205 - Bioengineering and Digital Health
30202 - Environmental Health
Forschungsfeld(er)
Enabling and Novel Technologies
Pioneer Campus
PSP-Element(e)
G-503800-001
G-540004-001
G-510007-001
Förderungen
National Health Service (NHS)
NCI
Common Fund of the Office of the Director of the National Institutes of Health
Helmholtz Association - Free State of Bavaria's Hightech Agenda through the Institute of AI for Health
European Union's Horizon Europe research and innovation program
Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
VALE
German Bundesministerium fr Bildung und Forschung (BMBF) through the Model Exchange for Regulatory Genomics project
NHGRI
NHLBI
NIDA
Diabetes UK
Cancer Research UK
British Heart Foundation
Welsh Government
Northwest Regional Development Agency
Wellcome Trust medical charity, Medical Research Council, Department of Health, Scottish Government
Answer ALS Consortium
NINDS
NIMH
Bundesministerium fr Bildung und Forschung (Federal Ministry of Education and Research)
Copyright
Erfassungsdatum
2025-05-09